Cvs Health (CVS) Total Non-Current Liabilities (2009 - 2026)
Cvs Health's (CVS) quarterly Total Non-Current Liabilities came in at $168.6 billion in Q1 2026, down 4.49% YoY from $176.6 billion in Q1 2025, and down 1.61% on a QoQ basis from $171.4 billion in Q4 2025.
Cvs Health (CVS) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Cvs Health (CVS) has 18 years of Total Non-Current Liabilities data on file, last reported at $168.6 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 4.49% year-over-year to $168.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168.6 billion (down 4.49% YoY) and the FY2025 annual result came in at $171.4 billion, down 1.6% from the prior year.
- Total Non-Current Liabilities declined to $168.6 billion in Q1 2026, from $171.4 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $180.3 billion in Q3 2025 to a low of $150.6 billion in Q2 2022.
- A 5-year average of $168.5 billion and a median of $172.3 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities climbed 15.38% — and 2026, when it declined 4.49%.
- Tracing CVS's Total Non-Current Liabilities over 5 years: stood at $153.3 billion in 2022, then increased by 10.81% to $169.8 billion in 2023, then rose by 2.55% to $174.2 billion in 2024, then declined by 1.6% to $171.4 billion in 2025, then declined by 1.61% to $168.6 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $168.6 billion (Q1 2026), $171.4 billion (Q4 2025), and $180.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Unitedhealth | 346.93 Bn | 315.46 Bn | 36.67 Bn | 184.04 Bn |
| 2 | Cvs Health | 119.91 Bn | 105.95 Bn | 47.23 Bn | 167.76 Bn |
| 3 | Elevance Health | 86.25 Bn | 50.30 Bn | 13.45 Bn | 77.13 Bn |
| 4 | Humana | 45.69 Bn | 21.82 Bn | 5.50 Bn | 34.99 Bn |
| 5 | Centene | 31.66 Bn | 4.60 Bn | 14.55 Bn | 57.55 Bn |
| 6 | Molina Healthcare | 10.12 Bn | 1.21 Bn | 1.43 Bn | 11.65 Bn |
| 7 | Oscar Health | 9.48 Bn | 922.10 Mn | 1.09 Bn | 9.12 Bn |
| 8 | Alignment Healthcare | 2.69 Bn | 1.99 Bn | 180.96 Mn | - |
| 9 | Clover Health Investments | 2.16 Bn | 1.92 Bn | 153.00 Mn | 323.33 Mn |
| 10 | Progyny | 2.03 Bn | 1.79 Bn | 89.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 167.76 Bn |
| Mar 31, 2026 | 168.63 Bn |
| Dec 31, 2025 | 171.39 Bn |
| Sep 30, 2025 | 180.28 Bn |
| Jun 30, 2025 | 176.01 Bn |
| Mar 31, 2025 | 176.55 Bn |
| Dec 31, 2024 | 174.17 Bn |
| Sep 30, 2024 | 173.99 Bn |
| Jun 30, 2024 | 174.18 Bn |
| Mar 31, 2024 | 172.32 Bn |
| Dec 31, 2023 | 169.84 Bn |
| Sep 30, 2023 | 173.60 Bn |
| Jun 30, 2023 | 173.80 Bn |
| Mar 31, 2023 | 164.52 Bn |
| Dec 31, 2022 | 153.28 Bn |
| Sep 30, 2022 | 156.88 Bn |
| Jun 30, 2022 | 150.63 Bn |
| Mar 31, 2022 | 154.06 Bn |
| Dec 31, 2021 | 152.53 Bn |
| Sep 30, 2021 | 155.19 Bn |